MARKET RADAR
SENSEX     NIFTY      
Moneycontrol.com India | Notes to Account > Pesticides/Agro Chemicals > Notes to Account from Rallis India - BSE: 500355, NSE: RALLIS
YOU ARE HERE > MONEYCONTROL > MARKETS > PESTICIDES/AGRO CHEMICALS > NOTES TO ACCOUNTS - Rallis India
Rallis India
BSE: 500355|NSE: RALLIS|ISIN: INE613A01020|SECTOR: Pesticides/Agro Chemicals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
  
LIVE
BSE
Feb 10, 17:00
135.35
-0.8 (-0.59%)
VOLUME 61,747
LIVE
NSE
Feb 10, 17:00
135.05
-1.75 (-1.28%)
VOLUME 153,010
Explore Rallis India connections « Mar 10
Notes to Accounts Year End : Mar '11
1.  Contingent Liabilities: -
 
 (a) Demands contested by the Company                   Rs. lacs
 
                                                   As at 31st March 
                                                 2011           2010
 
 - Sales Tax*                                  1,916.59     1,917.82
 
 - Excise Duty                                   360.84       378.77
 
 
 - Customs Duty                                  149.50       144.10
 
 - Income Tax                                  6,583.76     3,754.60
 
 - Service Tax                                    35.03         1.85
 
 - Property Cases                                 47.36        47.36
 
 - Labour Cases                                  103.75       156.71
 
 - Other Cases                                   453.79       449.82
 
 - Number of cases where amount is not 
   quantifiable 29 Nos; (Previous year 31 Nos)
 
 (b) Bills discounted                            338.56          Nil
 
 (c) Uncalled partly paid shares held as 
     Investments                                    Nil         4.34
 
 (d) Other guarantees issued by Bank for which the Company is
 contingently liable to Rs. 1.10 lacs (Previous Year Rs.2.00 lacs).
 These are covered by the charge created in favour of Companys bankers
 by way of hypothecation of stock and debtors.
 
 The Company does not expect any liability in respect of item (a), (b)
 and (d) to devolve in respect of its exposure and therefore no
 provision has been made in respect thereof.
 
 2.  Estimated amount of contracts remaining to be executed on capital
 account is Rs. 2,451.22 lacs (Previous Year Rs. 8,550.75 lacs) against
 which advances paid aggregate to Rs. 1,676.34 lacs (Previous Year
 Rs.3,145.49 lacs).
 
 3.  During the year, the Company acquired a majority of the equity
 shares of Metahelix Life Sciences Limited (Metahelix).  Besides, the
 shares already acquired, it has made the following commitments:
 
 (a) to acquire from certain shareholders (other than founder
 shareholders) 16,099 equity shares held by them for an amount
 aggregating Rs. 3,148.80 lacs;
 
 (b) to allow the founder shareholders, a put option exercisable over a
 period of 5 years, 14,055 shares held by them for an amount aggregating
 Rs. 2,749.02 lacs;
 
 At the end of 5 years, the Company has a call option to acquire the
 balance shares held by founder shareholders, at the fair market value
 as at the date of exercise.
 
 4.  The shareholders approved the issue of 6,482,296 fully paid up
 Equity Shares of Rs. 10 each as bonus share in the proportion of one
 bonus share for every two equity shares held by postal ballot on May
 29, 2010. Accordingly, a sum of Rs. 648.23 lacs has been transferred to
 Equity Share Capital Account from Capital Redemption Reserve Account.
 Consequently, the earnings per share have been adjusted for all the
 periods presented. As no cash flows were involved, the same has not
 been disclosed under financing activity.
 
 5.  Fixed assets include Rs. 449.45 lacs (Previous Year Rs. 720.14
 lacs) representing the book value of assets held for disposal.  The
 Management expects to recover amounts higher than the carrying value of
 these assets.
 
 6.  Amount payable to Micro, Small and Medium Enterprises are as
 follows:
 
 (a) The total amount of delayed payments during the year aggregates Rs.
 1,552.36 lacs in respect of 61 parties (Previous Year Rs. 1174.14 lacs
 in respect of 106 parties with amounts ranging from Rs. 0.01 lacs to
 Rs. 34.61 lacs) with amounts ranging from Rs. 0.01 lacs to Rs. 47.48
 lacs.
 
 (b) The amount of principal outstanding in respect of the above as at
 Balance Sheet date is Rs. 339.06 lacs in respect of 35 parties
 (Previous Year Rs. 387.20 lacs in respect of 90 parties with amounts
 ranging from Rs. 0.01 lacs to Rs. 171.41 lacs) with amounts ranging
 from Rs. 0.06 lacs to Rs. 83.39 lacs.
 
 (c) The total interest payable on account of delayed payment during the
 year is Rs. 17.09 lacs. The Company has made payments of Rs. 1.20 lacs
 during the year. The total interest payable aggregates to Rs. 40.78
 lacs (Previous Year Rs. 28.49 lacs) and this entire amount was
 outstanding as at the year end.
 
 7.  Secured Loans :-
 
 (a) Bank overdrafts and temporary loans have been secured by a first
 charge by way of hypothecation of stocks and receivables. The
 hypothecation also extends to guarantees issued by the Companys
 Bankers in the ordinary course of business.
 
 (b) Loans from others on account of purchase of vehicles have been
 secured by way of hypothecation of vehicles.
 
 (c) 750 Secured, Redeemable, Non Convertible Debentures 2010-11 Series
 I (Non Convertible Debentures) of face value of Rs. 10 lacs each were
 issued on 29.10.2010 amounting to Rs. 7,500.00 lacs with redemption
 period of 3 years at 9.05% rate of interest. These Non Convertible
 Debentures are secured by a first pari-passu mortgage over factory
 building and certain plant and machinery of Ankleshwar and Lote units.
 
 The terms of operating lease do not contain any exceptional /
 restrictive covenants.  Premises are taken by the Company on operating
 leases that are cancellable.
 
 8. “Sundry Debtors” include Rs. Nil (Previous Year Rs. Nil), being amount
 receivable from Rallis Australasia Pty. Ltd. (RAPL), a wholly owned
 subsidiary. The maximum amount outstanding during the year was Rs. 5.85
 lacs (Previous Year Rs.1,101.46 lacs).
 
 Also, included in “Loans and Advances” is a sum of Rs. 18.61 lacs
 (Previous Year Rs.18.61) being amount due from Rallis Chemistry Exports
 Ltd., a wholly owned subsidiary. The maximum amount outstanding during
 the year was Rs. 18.61 lacs (Previous Year Rs. 18.61 lacs).
 
 * includes amount of Rs. 364.14 lacs (Previous Year Rs. 129.37 lacs)
 paid to an external agency.
 
 # Recast
 
 During the year the Company has also incurred Rs. 445.98 lacs (Previous
 Year Rs. 271.31 lacs) towards product development and registration
 which is included under Capital Work in Progress (“CWIP”). The total
 amount included in CWIP as at 31st March 2011 Rs. 1,161.53 lacs
 (Previous Year Rs. 715.57 lacs). Out of the CWIP a sum of Rs. Nil lacs
 (Previous Year Rs. 398.44 lacs) was written off during the year.
 
 * Commission payable to Managing Director for the year 2010-11 includes
 Rs. 40 lacs relating to the previous year (Previous Year Rs. 5 lacs).
 
 # Commission payable to Non Whole Time Directors for the year 2009-10
 includes Rs. 5 lacs relating to the corresponding previous year.
 
 (b) Directors Remuneration
 
 The remuneration reported above excludes contributions to gratuity fund
 and provision for leave encashment since the same are ascertained on an
 aggregated basis for the Company as a whole by way of actuarial
 valuation and separate values attributable to the Managing Director are
 not available.
 
 9. “Other Income” includes net gain of Rs. 177.14 lacs (Previous Year
 net gain of Rs. 134.34 lacs grouped under “Other Income”) on account of
 foreign currency translation differences.
 
 10. Segment Reporting
 
 The Company has determined its business segment as “Agri - Inputs”
 comprising of Pesticides, Plant Growth Nutrients and Seeds. The other
 business segment comprises “Polymer” and is non reportable.
 
 b. Secondary Segment Information
 
 Figures in italics relate to the previous year.
 
 All tangible and intangible fixed assets of the Company are situated in
 India and therefore cost incurred during the year for
 acquisition of such assets under different geographic segments is not
 furnished.  
 
 Footnotes: 
 
 (i) Unallocable assets include Deferred Tax Assets, Investments,
 Advance Income Tax, Advance Fringe Benefits Tax and Interest Accrued on
 Investments.
 
 (ii) Unallocable liabilities includes Secured Loans, Unsecured Loans,
 Provisions for Equity Dividend and tax thereon, Provisions for
 Preference Dividend and tax thereon, Provision for Supplemental
 Payments on Retirement, Provision for Pension under Voluntary
 Retirement Schemes and Provision for Income and Fringe Benefit Tax.
 
 
 (iii) Unallocable income includes income from investment activities.
 
 (iv) Unallocable expenditure includes charge in respect of Supplemental
 Payments on retirement valued on actuarial basis.
 
 11. Related Party Disclosures
 
 Disclosure as required by Accounting Standard (AS) - 18 “Related Party
 Disclosures” as prescribed under section 211 (3C) of the Companies Act,
 1956.
 
 (a) Names of the related parties and description of relationship:
 
 (i) Promoters:                Tata Chemicals Limited
 
                               Tata Tea Limited - up to 18.08.2009
 
                               Tata Sons Limited - up to 18.08.2009
 
                               Tata Investment Corporation
 
                               Ewart Investments Limited
 
                               Tata AIG Life Insurance Co. Limited 
                               (w.e.f.- 21.05.2010)
 
 (ii) Holding Company:         Tata Chemicals Limited on and from 
                               09.11.2009
 
 (iii) Subsidiary Companies:   Rallis Australasia Pty. Ltd.
                               (Under liquidation from-31.03.2011) 
                               Rallis Chemistry Exports Ltd. as
                               and from 07.07.2009 Metahelix Life 
                               Sciences Ltd (w.e.f -30.12.2010)
                               Dhaanya Seeds Ltd. (w.e.f -30.12.2010)
 
 (iv) Key Management 
 Personnel:                    Mr.V.Shankar - Managing Director & CEO
 
 Footnotes: -
 
 (i) Licensed Capacity - Delicensed vide Gazette Notification No.
 S.O.477 (E) dated 25.07.1991.
 
 (ii) Figures in italics are in respect of the previous year.
 
 (iii) Production figures are net of captive consumption and exclude
 by-products (Previous Year Recast).
 
 (iv) Production includes quantities manufactured at sub-contracting
 plants. Installed capacity represents capacity installed at Companys
 facilities.
 
 (v) N.A. = Not Applicable.
 
 Footnote: -
 
 Figures in italics are in respect of the previous year.
 
 Out of investments made during the year disclosed above, Rs. 31,736.06
 lacs (Previous Year Rs. 67,914.74 lacs) were on account of switches not
 requiring the use of Cash and Cash Equivalents. Therefore, these
 amounts are not included under “Investing Activities” in the Cash Flow
 Statement.
 
 12.  The Company has invested Rs. 880.00 lacs in Non - Convertible
 Debentures (“NCDs”) of Advinus Therapeutics Pvt. Ltd.  having a coupon
 rate of 4.25%. The NCDs will be redeemed between December 2010 and May
 2013 at a premium of 25%. Income recognised during the year includes
 Rs. 30.44 lacs (Previous Year Rs. 33.32 lacs) in respect of redemption
 premium determined on the basis of the internal rate of return. During
 the year debentures amounting to Rs. 189.62 lacs were redeemed at a 25%
 premium which aggregated Rs. 47.96 lacs.
 
 13.  Foreign Currency Exposures :-
 
 The Company, in accordance with its risk management policies and
 procedures, enters into foreign currency forward contracts and currency
 option contracts to manage its exposure in foreign exchange rate
 variations. The counter party is generally a bank. These contracts are
 for a period between one day and four years.
 
 Derivative Instruments:
 
 The Company uses foreign currency forward contracts to hedge its risks
 associated with foreign currency fluctuations relating to certain firm
 commitments and forecasted transactions. The use of foreign currency
 forward contracts is governed by the Companys strategy approved by the
 Board of Directors, which provide principles on the use of such forward
 contracts consistent with the Companys Risk Management Policy. The
 Company does not use forward contracts for speculative purposes.
 
 The net gain on the derivative instrument of Rs. 73.66 lacs (net of
 Deferred Tax Liability of Rs. 35.38 lacs) is recognised in the Hedging
 Reserve Account as at 31st March, 2011 of which Rs. 62.02 lacs
 (Previous Year Rs. 64.49 lacs) is expected to be reclassified in the
 Profit and Loss Account by 31st March 2012.
 
 14. Employee Benefit Obligations
 
 Defined-Contribution Plans
 
 The Company makes contributions towards provident fund, family pension
 fund and superannuation fund to defined contribution retirement benefit
 plans for qualifying employees. The provident fund is administered by
 the Trustees of Rallis India Limited Provident Fund Trust, the family
 pension fund is administered by the Government of India and the
 superannuation fund is administered by the Life Insurance Corporation
 of India and HDFC Standard Life Insurance Company Ltd. Under the
 schemes, the Company is required to contribute a specified percentage
 of salary to the retirement benefit schemes to fund the benefit. The
 rules of the Companys Provident Fund administered by a Trust require
 that if the Board of Trustees are unable to pay interest at the rate
 declared by the Employees Provident Fund by the Government under
 paragraph 60 of the Employees Provident Fund Scheme, 1952 for the
 reason that the return on investment is less or for any other reason,
 then the deficiency shall be made good by the Company. Having regard to
 the assets of the Fund and the return on the investments, the Company
 does not expect any deficiency in the foreseeable future.
 
 A sum of Rs. 450.21 lacs (Previous Year Rs. 383.96 lacs) has been
 charged to the revenue account in this respect.
 
 Defined-Benefits Plans
 
 The Company offers its employees defined-benefit plans in the form of a
 gratuity scheme (a lump sum amount) and a supplemental pay scheme (a
 life long pension). Benefits under the defined benefit plans are
 typically based either on years of service and the employees
 compensation (generally immediately before retirement). The gratuity
 scheme covers substantially all regular employees, while supplemental
 pay plan covers certain executives. In the case of the gratuity scheme,
 the Company contributes funds to Gratuity Trust, which is irrevocable,
 while the supplemental pay scheme is not funded. Commitments are
 actuarially determined at year-end. The actuarial valuation is done
 based on “Projected Unit Credit” method. Gains and losses of changed
 actuarial assumptions are charged to the profit and loss account.
 
 The plan assets are managed by the Gratuity Trust formed by the
 Company. The management of funds is entrusted with the Life Insurance
 Corporation of India and HDFC Standard Life Insurance Company Limited.
 
 15.  Rallis Australasia Pty. Ltd., a subsidiary of the Company, has
 applied for voluntary liquidation as of 31st March, 2011.  The Company
 expects to recover an amount higher than the carrying value of the
 investment.
 
 16.  Previous years figures have been regrouped / restated wherever
 necessary to conform to the classification of the current year.
Source : Dion Global Solutions Limited
Quick Links for rallisindia
Follow moneycontrol.com

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.